Journal article icon

Journal article

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

Abstract:

PURPOSE: The prognosis of HIV-infected patients with non-Hodgkin lymphoma in the highly active antiretroviral therapy (HAART) era approaches that of the general population when they are treated with the same protocols. We analyzed the outcome of patients with Hodgkin lymphoma (HL) treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) in the HAART era according to HIV serostatus to establish whether this also holds true for HL. PATIENTS AND METHODS: From 1997 to 2010, 224 p...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1200/jco.2011.41.4193

Authors


Expand authors...
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume:
30
Issue:
33
Pages:
4111-4116
Publication date:
2012-11-01
DOI:
EISSN:
1527-7755
ISSN:
0732-183X
Source identifiers:
354210

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP